Newbridge Financial Services Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20
| Closed | -$2.3K | – | 1166 |
|
|
2024
Q3 | $2.3K | Hold |
20
| – | – | ﹤0.01% | 556 |
|
|
2024
Q2 | $2.75K | Sell |
20
-5
| -20% | -$688 | ﹤0.01% | 920 |
|
|
2024
Q1 | $3.45K | Buy |
25
+5
| +25% | +$690 | ﹤0.01% | 938 |
|
|
2023
Q4 | $2.64K | Sell |
20
-45
| -69% | -$5.93K | ﹤0.01% | 947 |
|
|
2023
Q3 | $7.31K | Hold |
65
| – | – | ﹤0.01% | 883 |
|
|
2023
Q2 | $6.13K | Hold |
65
| – | – | ﹤0.01% | 974 |
|
|
2023
Q1 | $6.58K | Hold |
65
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q4 | $7.76K | Hold |
65
| – | – | ﹤0.01% | 970 |
|
|
2022
Q3 | $7K | Hold |
65
| – | – | ﹤0.01% | 973 |
|
|
2022
Q2 | $6K | Sell |
65
-30
| -32% | -$2.77K | ﹤0.01% | 979 |
|
|
2022
Q1 | $9K | Hold |
95
| – | – | ﹤0.01% | 966 |
|
|
2021
Q4 | $8K | Hold |
95
| – | – | ﹤0.01% | 969 |
|
|
2021
Q3 | $9K | Sell |
95
-1
| -1% | -$95 | 0.01% | 904 |
|
|
2021
Q2 | $9K | Hold |
96
| – | – | 0.01% | 1012 |
|
|
2021
Q1 | $9K | Buy |
96
+46
| +92% | +$4.31K | 0.01% | 921 |
|
|
2020
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 853 |
|
|
2020
Q3 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 807 |
|